A History of Outperforming Analyst Forecasts and Beating the Odds: Akebia Therapeutics Inc (AKBA)

With 6.95 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.57 million shares. The 52-week range on AKBA shows that it touched its highest point at $4.08 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $7.40. Beta for the stock currently stands at 0.86.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AKBA was down-trending over the past week, with a drop of -1.92%, but this was up by 46.91% over a month. Three-month performance surged to 84.97% while six-month performance rose 74.15%. The stock gained 236.79% in the past year, while it has gained 87.89% so far this year. A look at the trailing 12-month EPS for AKBA yields -0.22 with Next year EPS estimates of 0.07. For the next quarter, that number is -0.01. This implies an EPS growth rate of 80.61% for this year and 215.62% for next year.

Float and Shares Shorts:

At present, 261.64 million AKBA shares are outstanding with a float of 251.87 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AKBA since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.26479 being high and -$0.34627 being low. For AKBA, this leads to a yearly average estimate of -$0.30553.

Sete News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.